We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » STATES, PRIVATE PLANS MAY ADOPT ASP METHODOLOGY
STATES, PRIVATE PLANS MAY ADOPT ASP METHODOLOGY
April 23, 2004
Drugmakers should expect to see the new methodology for determining the average sales price (ASP) of drugs spread to state Medicaid programs and commercial payers, despite continuing confusion in the industry about how ASP will be calculated for the purpose of setting Medicare Part B reimbursements, according to drug price-reporting experts.